Addressing large, unmet global markets with innovative proprietary products More »
Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »
Identifying early-stage companies with potential to increase value for shareholders More »
OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors and I would like to review several highlights.
OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE more »
OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations in Europe more »
OPKO Granted Patent from European Patent Office for Lagova™ more »
OPKO Health is an opportunistic research and development company that targets large, high-growth markets.